Published in Menopause on January 12, 2004
Videos to influence: a systematic review of effectiveness of video-based education in modifying health behaviors. J Behav Med (2012) 1.46
Knowledge about osteoporosis and its related factors among public health nurses in Taiwan. Osteoporos Int (2005) 0.93
Effectiveness of a community-based osteoporosis education and self-management course: a wait list controlled trial. Osteoporos Int (2009) 0.89
Effects of a DXA result letter on satisfaction, quality of life, and osteoporosis knowledge: a randomized controlled trial. BMC Musculoskelet Disord (2016) 0.86
The impact of osteoporosis prevention programs on calcium intake: a systematic review. Osteoporos Int (2013) 0.83
The impact of educational interventions on modifiable risk factors for osteoporosis after a fragility fracture. Osteoporos Int (2014) 0.76
A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures. Bonekey Rep (2014) 0.76
Evaluation of physical fitness in an ambulatory setting. Am J Obstet Gynecol (2007) 1.45
Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. Menopause (2002) 1.41
Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol (2005) 1.10
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy. Fertil Steril (2009) 1.10
Impact of physician gender on sexual history taking in a multispecialty practice. J Sex Med (2006) 1.10
Advancing primary care to promote equitable health: implications for China. Int J Equity Health (2012) 1.10
Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. Am J Obstet Gynecol (2008) 0.97
Insurance, racial/ethnic, SES-related disparities in quality of care among US adults with diabetes. J Immigr Minor Health (2014) 0.95
Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate. J Womens Health (Larchmt) (2009) 0.91
Sildenafil citrate for female sexual arousal disorder: a future possibility? Nat Rev Urol (2009) 0.89
Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.85
Chinese primary care physicians and work attitudes. Int J Health Serv (2013) 0.83
In vivo toxicity screening programs using metabonomics. Comb Chem High Throughput Screen (2002) 0.83
Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies. Eur J Obstet Gynecol Reprod Biol (2011) 0.82
Is elective vulvar plastic surgery ever warranted, and what screening should be conducted preoperatively? J Sex Med (2007) 0.82
Self-management, amitriptyline, and amitripyline plus triamcinolone in the management of vulvodynia. J Womens Health (Larchmt) (2009) 0.81
Vulvovaginal complaints. Clin Obstet Gynecol (2008) 0.80
Vulvar endometriosis presenting with dyspareunia: a case report. J Reprod Med (2012) 0.79
HPV vaccination with Gardasil: a breakthrough in women's health. Expert Opin Biol Ther (2006) 0.79
Menopausal women requesting egg/embryo donation: examining health screening guidelines for assisted reproductive technology. Menopause (2016) 0.78
Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.78
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. Curr Med Res Opin (2009) 0.78
Presenting symptoms among premenopausal and postmenopausal women with vulvodynia: a case series. Menopause (2015) 0.78
Premenopausal women with sexual dysfunction: the need for a bladder function history. J Sex Med (2007) 0.77
Cardiovascular outcomes after preeclampsia or eclampsia complicated by myocardial infarction or stroke. Obstet Gynecol (2012) 0.77
Postoperative fatigue negatively impacts the daily lives of patients recovering from hysterectomy. Obstet Gynecol (2002) 0.76
Estrogen--no matter how delivered--relieves postmenopausal vasomotor symptoms. Menopause (2003) 0.75
Recommendations for Self-report Outcome Measures in Vulvodynia Clinical Trials. Clin J Pain (2016) 0.75
Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot data. J Reprod Med (2006) 0.75
Differential diagnosis of seizure associated with topical lidocaine in a patient with vestibulodynia. J Low Genit Tract Dis (2009) 0.75
Finance issue brief: health purchasing alliances: an alternative for small employers: year end report-2003. Issue Brief Health Policy Track Serv (2003) 0.75
Finance issue brief: high-risk pools: coverage for the uninsurable: year end report-2003. Issue Brief Health Policy Track Serv (2003) 0.75
Practice of and attitudes towards family planning among South Asian American immigrants. Contraception (2013) 0.75
Evaluating the performance of pelvic floor exercises in women with urinary incontinence. J Reprod Med (2005) 0.75
The accuracy of women performing vaginal pH self-testing. J Womens Health (Larchmt) (2008) 0.75
Finance issue brief: mandated benefits: colorectal cancer screening coverage requirements: year end report-2003. Issue Brief Health Policy Track Serv (2003) 0.75
Finance issue brief: mandated benefits: prostate cancer screening coverage requirements: year end report-2003. Issue Brief Health Policy Track Serv (2003) 0.75
Satyriasis: the antiquity term for vulvodynia? J Sex Med (2006) 0.75
Quantifying estrogen treatment effect on vagina tissue: cellular age matters. Menopause (2006) 0.75
Milnacipran in provoked vestibulodynia: efficacy and predictors of treatment success. J Low Genit Tract Dis (2015) 0.75
Finance issue brief: women's health: emergency contraceptions: year end report-2003. Issue Brief Health Policy Track Serv (2003) 0.75